Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nejm head and neck cancer | 1.89 | 0.6 | 2952 | 5 |
pembrolizumab head and neck cancer nejm | 0.08 | 0.5 | 5638 | 94 |
head and neck cancer review nejm | 0.96 | 0.2 | 8277 | 39 |
head and neck cancer pubmed | 0.77 | 1 | 5872 | 90 |
head and neck cancer nih | 1.56 | 0.2 | 2214 | 40 |
head and neck cancer journal articles | 1.81 | 0.4 | 223 | 94 |
head and neck cancer journals | 0.77 | 0.4 | 3578 | 76 |
head and neck cancer ncbi | 1.88 | 0.9 | 520 | 48 |
cancer research uk head and neck cancer | 1.11 | 0.8 | 6331 | 22 |
head and neck cancer research | 1.02 | 0.6 | 4603 | 94 |
head and neck cancer patient | 1.51 | 0.1 | 6629 | 97 |
head and neck cancer epidemiology | 1.41 | 1 | 6513 | 60 |
neck and head cancer | 1.53 | 0.4 | 7588 | 82 |
suspected head and neck cancer | 0.2 | 0.2 | 7201 | 64 |
cdc head and neck cancer | 0.85 | 0.2 | 9065 | 30 |
head and neck cancer review | 1.96 | 0.7 | 7864 | 55 |
head and neck cancer clinical trials | 0.05 | 0.9 | 4834 | 38 |
head and neck cancer pathology | 1.92 | 0.2 | 7768 | 95 |
head and neck cancer outcomes | 1.91 | 0.5 | 8126 | 32 |